These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26780027)

  • 21. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.
    Lopardo HA; Vidal P; Sparo M; Jeric P; Centron D; Facklam RR; Paganini H; Pagniez NG; Lovgren M; Beall B
    J Clin Microbiol; 2005 Feb; 43(2):802-7. PubMed ID: 15695683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative epidemiology of Streptococcus pyogenes emm-types causing invasive and noninvasive infections in French children by use of high-resolution melting-polymerase chain reaction.
    d'Humières C; Bidet P; Levy C; Béchet S; Bonacorsi S; Bingen E; Cohen R
    Pediatr Infect Dis J; 2015 Jun; 34(6):557-61. PubMed ID: 25973933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreak of perianal Streptococcus pyogenes infection in a day-care center.
    Saxén H; Muotiala A; Rostila T; Vuopio-Varkila J
    Pediatr Infect Dis J; 1997 Feb; 16(2):247-9. PubMed ID: 9041610
    [No Abstract]   [Full Text] [Related]  

  • 24. Streptococcus pyogenes emm-types in northern Spain; population dynamics over a 7-year period.
    Tamayo E; Montes M; García-Arenzana JM; Pérez-Trallero E
    J Infect; 2014 Jan; 68(1):50-7. PubMed ID: 23999149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. vir types of Streptococcus pyogenes in Chennai, South India.
    Lloyd C; Balakrishnan N; Menon T
    J Med Microbiol; 2008 Sep; 57(Pt 9):1176-1177. PubMed ID: 18719193
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
    Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.
    Imöhl M; Reinert RR; Ocklenburg C; van der Linden M
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):389-96. PubMed ID: 20146737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of group A streptococci T serotype 1.
    Tanaka D; Yotaku G; Isobe J; Hosorogi S; Shimizu M; Katori K; Nagai Y; Fuchi Y; Yatsuyanagi J; Saito S; Kudaka J; Nakamura S
    Jpn J Infect Dis; 2002 Jun; 55(3):89-90. PubMed ID: 12195050
    [No Abstract]   [Full Text] [Related]  

  • 29. Group A streptococci. Erythromycin resistance and penicillin tolerance.
    Savoia D; Millesimo M; Dotti G; Milano F
    Adv Exp Med Biol; 1997; 418():447-9. PubMed ID: 9331690
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey.
    Oppegaard O; Mylvaganam H; Kittang BR
    Clin Microbiol Infect; 2015 Feb; 21(2):171-8. PubMed ID: 25658557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of invasive streptococcal infections.
    Cockerill FR; Schlievert PM; Musser JM
    J Infect Dis; 1998 Jun; 177(6):1773-4. PubMed ID: 9607873
    [No Abstract]   [Full Text] [Related]  

  • 32. High prevalence of streptococcal or Epstein-Barr virus infections in children with acute non-septic monoarthritis.
    Di Loreto S; Fabiano C; Nigro G
    New Microbiol; 2014 Jan; 37(1):81-6. PubMed ID: 24531174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global genomic epidemiology of Streptococcus pyogenes.
    Jespersen MG; Lacey JA; Tong SYC; Davies MR
    Infect Genet Evol; 2020 Dec; 86():104609. PubMed ID: 33147506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group A streptococcal infections in France. Clinical features and epidemiological markers. The Groupe d'Enquête 1995 sur les Infections Streptococciques.
    Varon E; Havlickova H; Gires A; Sarr A; Pitman C; Patey O; Goupy F; Kriz P; Bouvet A
    Adv Exp Med Biol; 1997; 418():229-31. PubMed ID: 9331639
    [No Abstract]   [Full Text] [Related]  

  • 35. Spectrum of beta-hemolytic streptococcal infections in a tertiary health centre.
    Khyriem AB; Parija SC; Sujatha S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):679-80. PubMed ID: 17883184
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.
    Darenberg J; Luca-Harari B; Jasir A; Sandgren A; Pettersson H; Schalén C; Norgren M; Romanus V; Norrby-Teglund A; Normark BH
    Clin Infect Dis; 2007 Aug; 45(4):450-8. PubMed ID: 17638193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)].
    Calle-Miguel L; Pérez-Méndez C; Miguel-Martínez MD; Lombraña-Álvarez E; García-García E; Solís-Sánchez G
    Rev Esp Quimioter; 2017 Apr; 30(2):90-95. PubMed ID: 28233483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Curative and prophylactic immunomodulation by vaccination in mucocutaneous streptococcal infections].
    Topciu V; Teodorescu M; Sedan D
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(1-2):71-3. PubMed ID: 8963122
    [No Abstract]   [Full Text] [Related]  

  • 39. Streptococcus pyogenes in general practice in Hong Kong.
    Fischbacher E
    J R Coll Gen Pract; 1968 Nov; 16(5):345-52. PubMed ID: 4881080
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development.
    Schuchat A; Wenger JD
    Epidemiol Rev; 1994; 16(2):374-402. PubMed ID: 7713185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.